Literature DB >> 33349883

Evolution of the monitoring and evaluation strategies to support the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis.

Patrick J Lammie1, Katherine M Gass2, Jonathan King3, Michael S Deming1, David G Addiss1, Gautam Biswas3, Eric A Ottesen2, Ralph Henderson2.   

Abstract

The Global Programme to Eliminate Lymphatic Filariasis (GPELF) was established with the ambitious goal of eliminating LF as a public health problem. The remarkable success of the GPELF over the past 2 decades in carrying out its principal strategy of scaling up and scaling down mass drug administration has relied first on the development of a rigorous monitoring and evaluation (M&E) framework and then the willingness of the World Health Organization and its community of partners to modify this framework in response to the practical experiences of national programmes. This flexibility was facilitated by the strong partnership that developed among researchers, LF programme managers and donors willing to support the necessary research agenda. This brief review summarizes the historical evolution of the GPELF M&E strategies and highlights current research needed to achieve the elimination goal.
© The Author(s) 2020. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.

Entities:  

Keywords:  disease elimination; lymphatic filariasis; mass drug administration; monitoring and evaluation

Mesh:

Substances:

Year:  2020        PMID: 33349883      PMCID: PMC7753166          DOI: 10.1093/inthealth/ihaa084

Source DB:  PubMed          Journal:  Int Health        ISSN: 1876-3405            Impact factor:   2.473


  14 in total

1.  Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study.

Authors:  Michael A Irvine; Wilma A Stolk; Morgan E Smith; Swaminathan Subramanian; Brajendra K Singh; Gary J Weil; Edwin Michael; T Deirdre Hollingsworth
Journal:  Lancet Infect Dis       Date:  2016-12-22       Impact factor: 25.071

Review 2.  Strategies and tools for the control/elimination of lymphatic filariasis.

Authors:  E A Ottesen; B O Duke; M Karam; K Behbehani
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

3.  A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasis.

Authors:  Katherine Gass; Madsen V E Beau de Rochars; Daniel Boakye; Mark Bradley; Peter U Fischer; John Gyapong; Makoto Itoh; Nese Ituaso-Conway; Hayley Joseph; Dominique Kyelem; Sandra J Laney; Anne-Marie Legrand; Tilaka S Liyanage; Wayne Melrose; Khalfan Mohammed; Nils Pilotte; Eric A Ottesen; Catherine Plichart; Kapa Ramaiah; Ramakrishna U Rao; Jeffrey Talbot; Gary J Weil; Steven A Williams; Kimberly Y Won; Patrick Lammie
Journal:  PLoS Negl Trop Dis       Date:  2012-01-17

4.  Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka.

Authors:  Ramakrishna U Rao; Sandhya D Samarasekera; Kumara C Nagodavithana; Tharanga D M Dassanayaka; Manjula W Punchihewa; Udaya S B Ranasinghe; Gary J Weil
Journal:  PLoS Negl Trop Dis       Date:  2017-10-30

5.  Partnering for impact: Integrated transmission assessment surveys for lymphatic filariasis, soil transmitted helminths and malaria in Haiti.

Authors:  Alaine Kathryn Knipes; Jean Frantz Lemoine; Franck Monestime; Carl R Fayette; Abdel N Direny; Luccene Desir; Valery E Beau de Rochars; Thomas G Streit; Kristen Renneker; Brian K Chu; Michelle A Chang; Kimberly E Mace; Kimberly Y Won; Patrick J Lammie
Journal:  PLoS Negl Trop Dis       Date:  2017-02-16

6.  Results of a confirmatory mapping tool for Lymphatic filariasis endemicity classification in areas where transmission was uncertain in Ethiopia.

Authors:  Heven Sime; Katherine M Gass; Sindew Mekasha; Ashenafi Assefa; Adugna Woyessa; Oumer Shafi; Kadu Meribo; Biruck Kebede; Kisito Ogoussan; Sonia Pelletreau; Moses J Bockarie; Amha Kebede; Maria P Rebollo
Journal:  PLoS Negl Trop Dis       Date:  2018-03-26

7.  A Trial of a Triple-Drug Treatment for Lymphatic Filariasis.

Authors:  Christopher L King; James Suamani; Nelly Sanuku; Yao-Chieh Cheng; Samson Satofan; Brooke Mancuso; Charles W Goss; Leanne J Robinson; Peter M Siba; Gary J Weil; James W Kazura
Journal:  N Engl J Med       Date:  2018-11-08       Impact factor: 91.245

Review 8.  A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis.

Authors:  Alison Krentel; Peter U Fischer; Gary J Weil
Journal:  PLoS Negl Trop Dis       Date:  2013-11-21

9.  Global programme to eliminate lymphatic filariasis: the processes underlying programme success.

Authors:  Kazuyo Ichimori; Jonathan D King; Dirk Engels; Aya Yajima; Alexei Mikhailov; Patrick Lammie; Eric A Ottesen
Journal:  PLoS Negl Trop Dis       Date:  2014-12-11

10.  The rationale and cost-effectiveness of a confirmatory mapping tool for lymphatic filariasis: Examples from Ethiopia and Tanzania.

Authors:  Katherine M Gass; Heven Sime; Upendo J Mwingira; Andreas Nshala; Maria Chikawe; Sonia Pelletreau; Kira A Barbre; Michael S Deming; Maria P Rebollo
Journal:  PLoS Negl Trop Dis       Date:  2017-10-04
View more
  1 in total

1.  Positive-case follow up for lymphatic filariasis after a transmission assessment survey in Haiti.

Authors:  Marisa A Hast; Alain Javel; Eurica Denis; Kira Barbre; Jonas Rigodon; Keri Robinson; Tara A Brant; Ryan Wiegand; Katherine Gass; Marc Aurèle Telfort; Christine Dubray
Journal:  PLoS Negl Trop Dis       Date:  2022-02-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.